Polypharmacy in older adults with human immunodeficiency virus infection compared with the general population

References

• LohseNHansenAPedersenGSurvival of persons with and without HIV infection in Denmark 1995–2005Ann Intern Med20071462879517227932
   PubMed Web of Science ®Google Scholar
• BlancoJRCaroAMPérez-CachafeiroSHIV infection and agingAIDS Rev201012421823021179186
   PubMed Web of Science ®Google Scholar
• Dirección General de Salud Pública, Calidad e Innovación. Informe de Evaluación. Plan Multisectorial de VIH-SIDA. 2008–2012Actualización a Diciembre de 2013 con datos epidemiológicos de 2012. [Public Health Department, Quality and Innovation. Evaluation report. Multisectorial AIDS Plan. 2008–2012. December 2013 update with epidemiological data of 2012]MadridMinisterio de Sanidad Servicios Sociales e Igualdad2013 Available from: https://www.msssi.gob.es/ciudadanos/enfLesiones/enfTransmisibles/sida/docs/informeEvaluacion30Agosto2013.pdfAccessed December 1, 2015
   Google Scholar
• RayMLoganRSterneJAHIV-CAUSAL CollaborationThe effect of combined antiretroviral therapy on the overall mortality of HIV-infected individualsAIDS201024112313719770621
   PubMed Web of Science ®Google Scholar
• SamjiHCesconAHoggRSClosing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and CanadaPLoS One2013812613
   Web of Science ®Google Scholar
• SmitMBrinkmanKGeerlingsSFuture challenges for clinical care of an ageing population infected with HIV: a modelling studyLancet Infect Dis201515781081826070969
   PubMed Web of Science ®Google Scholar
• Work Group for The HIV and Aging Consensus ProjectSummary report from the human immunodeficiency virus and aging consensus project: treatment strategies for managing older individuals with human immunodeficiency virusJ Am Geriatr Soc201260597497922568508
   PubMed Web of Science ®Google Scholar
• Grupo de expertos de la Secretaría del Plan Nacional sobre el SIDA (SPNS), Sociedad Española de Geriatría y Gerontología (SEGG)Documento de consenso sobre edad avanzada e infección por el virus de la inmunodeficiencia humana (Noviembre 2015). [Expert Group of National AIDS Plan (SPNS), Spanish Society of Geriatrics and Gerontology (SEGG). Consensus Document on Elderly and Infection of HIV (November 2015)]MadridMinisterio de Sanidad Servicios Sociales e Igualdad2015 Available from: http://www.msssi.gob.es/ciudadanos/enfLesiones/enfTransmisibles/sida/publicaciones/profSanitarios/docEdadAvanzadaVIH.pdfAccessed December 1, 2015
   Google Scholar
• GuaraldiGOrlandoGZonaSPremature age-related comorbidities among HIV-infected persons compared with the general populationClin Infect Dis201153111120112621998278
   PubMed Web of Science ®Google Scholar
• Panel on Antiretroviral Guidelines for Adults and AdolescentsGuidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and AdolescentsDepartment of Health and Human Services Internet2016 Available from: http://aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdfAccessed January 1, 2016
   Google Scholar
• SchoutenJWitFWStolteIGCross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort studyClin Infect Dis201459121787179725182245
   PubMed Web of Science ®Google Scholar
• EdelmanEJGordonKSGloverJMcNichollIRFiellinDAJusticeACThe next therapeutic challenge in HIV: polypharmacyDrugs Aging201330861362823740523
   PubMed Web of Science ®Google Scholar
• Cantudo-cuencaMRJiménez-GalánRAlmeida-GonzálezCVMorillo-VerdugoRConcurrent use of comedications reduces adherence to antiretroviral therapy among HIV-infected patientsJ Manag Care Pharm2014208844850
   Google Scholar
• NachegaJBHsuAJUthmanOASpinewineAPhamPAAntiretroviral therapy adherence and drug–drug interactions in the aging HIV populationAIDS201226Suppl 1S39S5322781176
   PubMedGoogle Scholar
• GleasonLJLuqueAEShahKPolypharmacy in the HIV-infected older adult populationClin Interv Aging2013874976323818773
   PubMed Web of Science ®Google Scholar
• MarzoliniCBackDWeberRAgeing with HIV: medication use and risk for potential drug-drug interactionsJ Antimicrob Chemother20116692107211121680580
   PubMed Web of Science ®Google Scholar
• HoltzmanCArmonCTedaldiEthe HOPS InvestigatorsPolypharmacy and risk of antiretroviral drug interactions among the aging hiv-infected populationJ Gen Intern Med201328101302131023605401
   PubMed Web of Science ®Google Scholar
• GreeneMSteinmanMMcNichollIValcourVPolypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults with human immunodeficiency virus infectionJ Am Geriatr Soc201462344745324576251
   PubMed Web of Science ®Google Scholar
• TsengASzadkowskiLWalmsleySSalitIRaboudJAssociation of age with polypharmacy and risk of drug interactions with antiretroviral medications in HIV-positive patientsAnn Pharmacother201347111429143924285760
   PubMed Web of Science ®Google Scholar
• MarzoliniCElziLGibbonsSPrevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV cohort studyAntivir Ther201015341342320516560
   PubMed Web of Science ®Google Scholar
• SchmiemannGBahrMGurjanovAHummers-PradierEDifferences between patient medication records held by general practitioners and the drugs actually consumed by the patientsInt J Clin Pharmacol Ther201250861461722762854
   PubMed Web of Science ®Google Scholar
• FurlerMEinarsonTWalmsleySMillsonMBendayanRPolypharmacy in HIV: impact of data source and gender on reported drug utilizationAIDS Patients Care STDS20041810568586
   PubMed Web of Science ®Google Scholar
• Gimeno-GraciaMCrusells-CanalesMJJavier Armesto-GómezFRabanaque-HernándezMJPrevalence of concomitant medications in older HIV+ patients and comparison with general populationHIV Clin Trials201516311712425978302
   PubMed Web of Science ®Google Scholar
• Núñez MontenegroAJMontiel LuqueAMartín AuriolesETorres VerdúBLara MorenoCGonzález CorreaJAen representación del grupo PolipresactAdherencia al tratamiento en pacientes polimedicados mayores de 65 años con prescripción por principio activo. [Adherence to treatment, by active ingredient, in patient over 65 years on multiple medication]Atención Primaria201446523824524378196
   PubMed Web of Science ®Google Scholar
• Garrido-GarridoEMGarcía-GarridoIGarcía-López-DuránJCGarcía-JiménezFOrtega-LópezIBueno-CavanillasAEstudio de pacientes polimedicados mayores de 65 años en un centro de asistencia primaria urbano. [Study of polymedicated patients over 65 years-old in an urban primary care centre]Rev Calid Asist2011262909621349755
   PubMedGoogle Scholar
• RichardsonKAnanouALafortuneLBrayneCMatthewsFEVariation over time in the association between polypharmacy and mortality in the older populationDrugs Aging201128754756021721599
   PubMed Web of Science ®Google Scholar
• GnjidicDHilmerSNBlythFMPolypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomesJ Clin Epidemiol201265998999522742913
   PubMed Web of Science ®Google Scholar
• WHO Collaborating Centre for Drug Statistics MethodologyATC/DDD Classification Index with DDDsOslo2015 Available from: http://www.whocc.no/atc_ddd_index/Accessed June 1, 2015
   Google Scholar
• MaloSRabanaqueMJFejaCLallanaMJAguilarIBjerrumLHigh antibiotic consumption: a characterization of heavy users in SpainBasic Clin Pharmacol Toxicol2014115323123624517562
   PubMed Web of Science ®Google Scholar
• Malo-FumanalSRabanaque-HernándezMJFeja-SolanaCLallana-AlvarezMJArmesto-GómezJBjerrumLDiferencias en el uso extrahospitalario de antibióticos entre una región española y un país nórdico. [Differences in outpatient antibiotic use between a Spanish region and a Nordic country]Enferm Infecc Microbiol Clin201432741241724262316
   PubMed Web of Science ®Google Scholar
• BurkholderGATamhaneARSalinasJLUnderutilization of aspirin for primary prevention of cardiovascular disease among HIV-infected patientsClin Infect Dis201255111550155722942209
   PubMed Web of Science ®Google Scholar
• SuchindranSReganSMeigsJGrinspoonSTriantVAspirin use for primary and secondary prevention in human immunodeficiency virus (HIV)-infected and HIV-uninfected patientsOpen Forum Infect Dis201413ofu07625734156
   PubMedGoogle Scholar
• FreibergMSLeafDAGouletJLThe association between the receipt of lipid lowering therapy and HIV status among veterans who met NCEP/ATP III criteria for the receipt of lipid lowering medicationJ Gen Intern Med200924333434019127386
   PubMed Web of Science ®Google Scholar
• GouletJLFultzSLRimlandDAging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity?Clin Infect Dis200745121593160118190322
   PubMed Web of Science ®Google Scholar
• JusticeACMcGinnisKAAtkinsonJHPsychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: Veterans Aging Cohort Five-Site StudyAIDS200418Suppl 1S49S5915075498
   PubMed Web of Science ®Google Scholar
• Grupo de estudio del SIDA-SEIMCDocumento de prevención y tratamiento de infecciones oportunistas y otras coinfecciones en pacientes con infección por VIH. [Study Group of AIDS. Document of Prevention and Treatment of Opportunistic Infections and other co-infections in HIV-positive patients]Madrid2015 Available from: http://www.gesida-seimc.org/contenidos/guiasclinicas/2015/gesida-guiasclinicas-2015-InfeccionesOportunistasyCoinfeccionesVIH.pdfAccessed February 1, 2016
   Google Scholar
• Zapata-CachafeiroMGonzález-GonzálezCVáquez-LagoJMDeterminants of antibiotic dispensing without a medical prescription: a cross-sectional study in the north of SpainJ Antimicrob Chemother201469113156316024966275
   PubMed Web of Science ®Google Scholar
• RollasonVVogtNReduction of polypharmacy in the elderly: a systematic review of the role of the pharmacistDrugs Aging2003201181783212964888
   PubMed Web of Science ®Google Scholar